Karyopharm Therapeutics | KPTI - Market Capitalization

Stock Price
5.21
Daily Change
-0.24 -4.32%
Monthly
-44.33%
Yearly
7.32%
Q1 Forecast
7.40

Karyopharm Therapeutics reported $626M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Abbott USD 217.86B 15.25B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 220.14B 68B Mar/2026
BioCryst Pharmaceuticals USD 1.7B 40M Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
MacroGenics USD 192M 90M Mar/2026
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 240.48B 51.73B Mar/2026
Novartis USD 303.66B 40.58B Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Tectonic Therapeutic USD 474M 84M Mar/2026
TG Therapeutics USD 4.73B 1B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Xencor USD 1.09B 256M Dec/2025